tyrosine kinase with immunoglobulin like and EGF like domains 1 | Type XII RTKs: TIE family of angiopoietin receptors | IUPHAR/BPS Guide to PHARMACOLOGY

Top ▲

tyrosine kinase with immunoglobulin like and EGF like domains 1

Target not currently curated in GtoImmuPdb

Target id: 1841

Nomenclature: tyrosine kinase with immunoglobulin like and EGF like domains 1

Abbreviated Name: TIE1

Family: Type XII RTKs: TIE family of angiopoietin receptors

Annotation status:  image of an orange circle Annotated and awaiting review. Please contact us if you can help with reviewing.  » Email us

Gene and Protein Information
Species TM AA Chromosomal Location Gene Symbol Gene Name Reference
Human 1 1138 1p34-p33 TIE1 tyrosine kinase with immunoglobulin like and EGF like domains 1
Mouse 1 1134 4 Tie1 tyrosine kinase with immunoglobulin-like and EGF-like domains 1
Rat - 1137 5q36 Tie1 tyrosine kinase with immunoglobulin-like and EGF-like domains 1
Previous and Unofficial Names
TIE | tyrosine kinase receptor 1 | tyrosine kinase with immunoglobulin-like and EGF-like domains 1
Database Links
BRENDA
CATH/Gene3D
ChEMBL Target
Ensembl Gene
Entrez Gene
Human Protein Atlas
KEGG Enzyme
KEGG Gene
OMIM
RefSeq Nucleotide
RefSeq Protein
UniProtKB
Wikipedia
Enzyme Reaction
EC Number: 2.7.10.1

Download all structure-activity data for this target as a CSV file

Inhibitors
Key to terms and symbols View all chemical structures Click column headers to sort
Ligand Sp. Action Value Parameter Reference
merestinib Hs Inhibition 9.1 pKd 4
pKd 9.1 (Kd 9x10-10 M) [4]
Description: Binding constant assessed by KINOMEScan assay.
compound R-16 [PMID: 21967808] Hs Inhibition - - 2
[2]
Description: Measured as % inhibition using 1μM compound.
Inhibitor Comments
TIE1 activity is inhibited by 98% in the presence of 1μM compound R-16 [PMID 21967808] [2].
DiscoveRx KINOMEscan® screen
A screen of 72 inhibitors against 456 human kinases. Quantitative data were derived using DiscoveRx KINOMEscan® platform.
http://www.discoverx.com/services/drug-discovery-development-services/kinase-profiling/kinomescan
Reference: 1,3

Key to terms and symbols Click column headers to sort
Target used in screen: TIE1
Ligand Sp. Type Action Value Parameter
AST-487 Hs Inhibitor Inhibition 9.5 pKd
foretinib Hs Inhibitor Inhibition 9.1 pKd
doramapimod Hs Inhibitor Inhibition 8.1 pKd
NVP-TAE684 Hs Inhibitor Inhibition 7.8 pKd
staurosporine Hs Inhibitor Inhibition 7.2 pKd
sorafenib Hs Inhibitor Inhibition 7.2 pKd
tamatinib Hs Inhibitor Inhibition 7.1 pKd
axitinib Hs Inhibitor Inhibition 7.0 pKd
crizotinib Hs Inhibitor Inhibition 7.0 pKd
linifanib Hs Inhibitor Inhibition 7.0 pKd
Displaying the top 10 most potent ligands  View all ligands in screen »

References

Show »

1. Davis MI, Hunt JP, Herrgard S, Ciceri P, Wodicka LM, Pallares G, Hocker M, Treiber DK, Zarrinkar PP. (2011) Comprehensive analysis of kinase inhibitor selectivity. Nat. Biotechnol., 29 (11): 1046-51. [PMID:22037378]

2. Milkiewicz KL, Aimone LD, Albom MS, Angeles TS, Chang H, Grobelny JV, Husten J, Losardo C, Miknyoczki S, Murthy S et al.. (2011) Improvement in oral bioavailability of 2,4-diaminopyrimidine c-Met inhibitors by incorporation of a 3-amidobenzazepin-2-one group. Bioorg. Med. Chem., 19 (21): 6274-84. [PMID:21967808]

3. Wodicka LM, Ciceri P, Davis MI, Hunt JP, Floyd M, Salerno S, Hua XH, Ford JM, Armstrong RC, Zarrinkar PP et al.. (2010) Activation state-dependent binding of small molecule kinase inhibitors: structural insights from biochemistry. Chem. Biol., 17 (11): 1241-9. [PMID:21095574]

4. Yan SB, Peek VL, Ajamie R, Buchanan SG, Graff JR, Heidler SA, Hui YH, Huss KL, Konicek BW, Manro JR et al.. (2013) LY2801653 is an orally bioavailable multi-kinase inhibitor with potent activity against MET, MST1R, and other oncoproteins, and displays anti-tumor activities in mouse xenograft models. Invest New Drugs, 31 (4): 833-44. [PMID:23275061]

How to cite this page

Type XII RTKs: TIE family of angiopoietin receptors: tyrosine kinase with immunoglobulin like and EGF like domains 1. Last modified on 24/04/2019. Accessed on 22/07/2019. IUPHAR/BPS Guide to PHARMACOLOGY, http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1841.